NS
MRNA icon

NBC Securities’s Moderna MRNA Stock Holding History

NBC Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25K Sell
493
-49
-9% -$2.29K ﹤0.01% 1619
2025
Q4 		$16K Buy
542
+75
+16% +$2.04K ﹤0.01% 1859
2025
Q3 		$12.1K Buy
467
+311
+199% +$8.68K ﹤0.01% 1953
2025
Q2 		$4K Buy
156
+1
+0.6% +$26 ﹤0.01% 2164
2025
Q1 		$4K Buy
+155
New +$5.5K ﹤0.01% 1923
2024
Q4 		– Sell
-577
Closed -$38K – 1776
2024
Q3 		$38K Sell
577
-24
-4% -$2.2K ﹤0.01% 1256
2024
Q2 		$71K Sell
601
-553
-48% -$70K 0.01% 1039
2024
Q1 		$122K Sell
1,154
-68
-6% -$6.85K 0.01% 896
2023
Q4 		$121K Buy
1,222
+205
+20% +$17.2K 0.01% 891
2023
Q3 		$105K Buy
+1,017
New +$113K 0.01% 920

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return